1. Home
  2. MBIO vs SPHL Comparison

MBIO vs SPHL Comparison

Compare MBIO & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.67

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$2.78

Market Cap

5.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
SPHL
Founded
2015
2002
Country
United States
Singapore
Employees
N/A
73
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
SPHL
Price
$0.67
$2.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
65.3K
2.1M
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.35
52 Week High
$7.00
$25.11

Technical Indicators

Market Signals
Indicator
MBIO
SPHL
Relative Strength Index (RSI) 46.14 47.10
Support Level $0.58 $2.24
Resistance Level $0.82 $3.08
Average True Range (ATR) 0.08 1.41
MACD -0.00 -0.12
Stochastic Oscillator 19.63 4.69

Price Performance

Historical Comparison
MBIO
SPHL

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: